Back to GetFilings.com



Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

[x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2003

OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                 to                

Commission File Number 0-20981

DOCUMENT SCIENCES CORPORATION
(Exact name of registrant as specified in its charter)

     
Delaware
(State or Other Jurisdiction of Incorporation or Organization)
  33-0485994
(IRS Employer Identification No.)

6339 Paseo del Lago
Carlsbad, California 92009

(Address of Principal Executive Offices including Zip Code)

(760) 602-1400
(Registrant’s Telephone Number including Area Code)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). Yes [  ] No [X]

As of May 12, 2003, there were 3,874,730 shares of common stock of the registrant outstanding.



 


TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION
ITEM 1—FINANCIAL STATEMENTS (Unaudited)
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED STATEMENTS OF OPERATIONS
CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
ITEM 4. CONTROLS AND PROCEDURES
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
ITEM 5. OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
SIGNATURES
CERTIFICATION
EXHIBIT INDEX
EXHIBIT 99.1


Table of Contents

DOCUMENT SCIENCES CORPORATION

                 
            Page
            No.
 
  PART I. FINANCIAL INFORMATION        
Item 1
  Financial Statements (Unaudited)        
 
  Consolidated balance sheets     3  
 
  Consolidated statements of operations     4  
 
  Consolidated statements of cash flows     5  
 
  Notes to condensed consolidated financial statements     6  
Item 2
  Management's Discussion and Analysis of Financial Condition and Results of Operations     9  
Item 3
  Quantitative and Qualitative Disclosures About Market Risk     21  
Item 4
  Controls and Procedures     21  
 
  PART II. OTHER INFORMATION        
Item 1
  Legal Proceedings     22  
Item 4
  Submission of Matters to a Vote of Security Holders     22  
Item 5
  Other Information     22  
Item 6
  Exhibits and Reports on Form 8-K     22  
Signatures
            24  
Certifications
            25  

2


Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1—FINANCIAL STATEMENTS (Unaudited)

DOCUMENT SCIENCES CORPORATION
CONSOLIDATED BALANCE SHEETS

                     
        March 31,   December 31,
        2003   2002
       
 
        (Unaudited)   (See note below)
ASSETS
               
Current assets:
               
 
Cash and cash equivalents
  $ 1,834,745     $ 2,284,367  
 
Short-term investments
    7,866,343       6,294,838  
 
Accounts receivable, net
    3,879,668       7,223,750  
 
Due from affiliates
    1,075,437       1,242,196  
 
Unbilled revenue
    15,076       161,159  
 
Other current assets
    784,584       756,268  
 
 
   
     
 
   
Total current assets
    15,455,853       17,962,578  
Property and equipment, net
    964,072       781,874  
Software development costs, net
    1,577,886       1,518,102  
Goodwill, net
    724,615       724,615  
Other assets
    194,046       197,497  
 
 
   
     
 
   
Total assets
  $ 18,916,472     $ 21,184,666  
 
 
   
     
 
LIABILITIES
               
Current liabilities:
               
 
Accounts payable
  $ 210,605     $ 192,945  
 
Accrued compensation
    832,099       1,580,521  
 
Other accrued liabilities
    269,452       495,679  
 
Deferred revenue
    9,263,416       9,689,774  
 
 
   
     
 
   
Total current liabilities
    10,575,572       11,958,919  
Obligations under capital leases
    85,021        
Deferred revenue — long-term
    22,405       44,810  
STOCKHOLDERS’ EQUITY
               
 
Common stock, $.001 par value
    3,875       3,858  
 
Additional paid-in capital
    10,814,807       10,786,007  
 
Accumulated comprehensive income
    (2,290 )     10,981  
 
Retained deficit
    (2,582,918 )     (1,619,909 )
 
 
   
     
 
   
Total stockholders’ equity
    8,233,474       9,180,937  
 
 
   
     
 
   
Total liabilities and stockholders’ equity
  $ 18,916,472     $ 21,184,666  
 
 
   
     
 

Note: The balance sheet at December 31, 2002 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. See notes to consolidated financial statements.

3


Table of Contents

DOCUMENT SCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS

                     
        Three Months Ended
        March 31,
       
        2003   2002
       
 
Revenues:
               
 
Initial license fees
  $ 1,047,870     $ 1,355,031  
 
Annual renewal license and support fees
    2,599,839       2,295,959  
 
Services and other
    960,958       1,195,641  
 
 
   
     
 
   
Total revenues
    4,608,667       4,846,631  
Cost of revenues:
               
 
Initial license fees
    265,551       350,314  
 
Annual renewal license and support fees
    373,815       375,320  
 
Services and other
    680,782       677,679  
 
 
   
     
 
   
Total cost of revenues
    1,320,148       1,403,313  
 
 
   
     
 
Gross margin
    3,288,519       3,443,318  
Operating expenses:
               
 
Research and development
    1,403,552       1,626,513  
 
Selling and marketing
    2,198,803       1,676,612  
 
General and administrative
    689,834       744,562  
 
 
   
     
 
   
Total operating expenses
    4,292,189       4,047,687  
 
 
   
     
 
Loss from operations
    (1,003,670 )     (604,369 )
 
Interest and other income, net
    64,070       15,443  
 
 
   
     
 
Loss before income taxes
    (939,600 )     (588,926 )
 
Provision for income taxes
    23,410        
 
 
   
     
 
Net loss
  $ (963,010 )   $ (588,926 )
 
 
   
     
 
Net loss per share—basic
  $ (0.25 )   $ (0.15 )
 
 
   
     
 
Weighted average shares used in basic calculation
    3,869,878       3,848,659  
 
 
   
     
 
Net loss per share—diluted
  $ (0.25 )   $ (0.15 )
 
 
   
     
 
Weighted average shares used in diluted calculation
    3,869,878       3,848,659  
 
 
   
     
 

See notes to consolidated financial statements.

4


Table of Contents

DOCUMENT SCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS

                     
        Three Months Ended
        March 31,
       
        2003   2002
       
 
Operating activities
               
Net loss
  $ (963,010 )   $ (588,926 )
Adjustments to reconcile net loss to net cash provided by operating activities:
               
 
Depreciation and amortization
    105,043       137,812  
 
Loss on disposal of fixed assets
    123       22,970  
 
Amortization of software development costs
    158,496       280,681  
 
Provision for doubtful accounts
    (618 )     (6,435 )
 
Changes in operating assets and liabilities:
               
   
Accounts receivable
    3,345,052       871,448  
   
Due from affiliates
    170,784       444,978  
   
Unbilled revenue
    146,083       (24,799 )
   
Other assets
    (24,532 )     (76,665 )
   
Accounts payable
    17,339       (49,232 )
   
Accrued compensation
    (748,437 )     (195,278 )
   
Other accrued liabilities
    (249,254 )     111,773  
   
Deferred revenue
    (449,298 )     (129,886 )
 
   
     
 
Net cash provided by operating activities
    1,507,771       798,441  
Investing activities
               
Purchases of short-term investments
    (2,626,173 )     (1,130,314 )
Maturities of short-term investments
    1,025,000       1,484,000  
Purchases of property and equipment, net
    (179,391 )     (8,381 )
Proceeds from disposal of assets
    1,460       6,394  
Additions to software development costs
    (218,280 )     (163,059 )
 
   
     
 
Net cash provided by (used in) investing activities
    (1,997,384 )     188,640  
Financing activities
               
Principal payments under capital lease obligations
    (1,735 )      
Reduction of debt
          (2,451,170 )
Purchase of treasury stock
          (48,311 )
Sale of treasury stock
          213  
Issuance of common stock
    28,817       28,766  
 
   
     
 
Net cash provided by (used in) financing activities
    27,082       (2,470,502 )
 
   
     
 
Decrease in cash and cash equivalents
    (462,531 )     (1,483,421 )
Effect of foreign currency on cash
    12,909       (8,778 )
Cash and cash equivalents at beginning of period
    2,284,367       3,187,229  
 
   
     
 
Cash and cash equivalents at end of period
  $ 1,834,745     $ 1,695,030  
 
   
     
 
Supplemental disclosure of cash flow information:
               
Interest paid
  $     $ 171,970  
 
   
     
 
Capital lease obligations entered into for property and equipment
  $ 109,313     $  
 
   
     
 

See notes to consolidated financial statements.

5


Table of Contents

DOCUMENT SCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
March 31, 2003

Note A—Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, certain information and footnotes disclosures normally included in complete financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the statements include all adjustments necessary, which are of a normal and recurring nature, for the fair presentation of our financial position and of the results for the interim periods presented.

These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2002, included in Document Sciences Corporation Annual Report on Form 10-K filed with the Securities and Exchange Commission. Operating results for the three months ended March 31, 2003 are not necessarily indicative of the results that may be expected for any other interim period or for the year ending December 31, 2003. The balance sheet at December 31, 2002 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. Certain amounts for 2002 have been reclassified to conform with the 2003 presentation.

We recognize revenue in accordance with Statement of Position (SOP) 97-2, Software Revenue Recognition and Staff Accounting Bulletin (SAB) No. 101, Revenue Recognition in Financial Statements. Initial license fees are recognized when a contract exists, the fee is fixed and determinable, software delivery has occurred and collection of the receivable is deemed probable. We use the residual method to recognize revenue for all of our license models. Our contracts specifically state the amount of initial and annual license fees due for each type of software licensed. If an undelivered element of the arrangement exists under the license arrangement, revenue is deferred based on vendor-specific objective evidence of the fair value of the undelivered element. If vendor-specific objective evidence of fair value does not exist for all undelivered elements, all revenue is deferred until sufficient evidence exists or all elements have been delivered. We recognize revenue on transactions with payment terms less than twelve months from the contract date if we have a history of successfully collecting from the specific customer without providing concessions. Amounts billed or payments received in advance of revenue recognition are recorded as deferred revenue.

Our goodwill was purchased on May 7, 1997, and had been amortized on a straight-line basis over 15 years. On January 1, 2002, we adopted Statement of Financial Accounting Standards (SFAS) No. 142, Goodwill and Other Intangible Assets and ceased amortizing our goodwill. Pursuant to this adoption, we reassessed the underlying value of our goodwill by analyzing future net cash flows and determined that no adjustment to the carrying value was required.

Note B—Transactions with Affiliates

We have distribution agreements with affiliates of Xerox Corporation providing for the non-exclusive right to sub-license our software in Europe, Australia, Canada and Latin America. The terms of the

6


Table of Contents

DOCUMENT SCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
March 31, 2003

distributor agreements provide that the affiliates receive a discount from the list price of our licensed products and annual license fees. We also have agreements with affiliates of Xerox providing the non-exclusive right to sub-license our software in the United States. Revenues from these affiliates, net of discounts, were $982,100 and $755,400 for the three months ended March 31, 2003 and 2002, respectively. Included in accounts receivable are $1.1 million and $1.3 million from these revenues at March 31, 2003 and 2002, respectively.

Note C—Computation of Net Income Per Share

We present our earnings per share information in accordance with SFAS No. 128, Earnings per Share (EPS). Basic EPS is computed by dividing income or loss available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Shares issued during the period and shares reacquired during the period are weighted for the portion of the period that they were outstanding. Basic EPS excludes any dilutive effects of options, warrants and convertible securities.

The computation of diluted EPS is similar to the computation of basic EPS, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the common shares underlying outstanding options and warrants had been issued. The dilutive effect of outstanding options and warrants has been reflected in EPS by application of the treasury stock method. The treasury stock method recognizes the use of proceeds that could be obtained upon exercise of options and warrants in computing diluted EPS. It assumes that any proceeds would be used to purchase common stock at the average market price during the period. Options and warrants will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options or warrants.

The following table reconciles the shares used in computing basic and diluted EPS for the periods indicated:

                 
    Three Months Ended
   
    March 31,   March 31,
    2003   2002
   
 
Weighted average common shares outstanding used in basic earnings per share calculation
    3,869,878       3,848,659  
Effect of dilutive stock options
           
 
   
     
 
Shares used in diluted earnings per share
    3,869,878       3,848,659  
 
   
     
 

Note D—Stock-Based Compensation

As permitted by SFAS No. 123, Accounting for Stock-based Compensation, we have elected to follow Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations in accounting for our employee stock options. Under APB Opinion No. 25, among other things, when the exercise price of our employee stock options is not less than the market price of the underlying stock on the date of grant, no compensation expense is recognized.

As required under SFAS No. 123, Accounting for Stock-Based Compensation, and SFAS No. 148, Accounting for Stock-Based Compensation — Transition and Disclosure, the pro forma effects of stock-based compensation on net income and net earnings per common share have been estimated at the date of grant using the Black-Scholes option pricing model based on the following weighted-average

7


Table of Contents

DOCUMENT SCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
March 31, 2003

assumptions: risk-free interest rates of 4%, dividend yields of 0%, expected volatility of .58 to .94 and a weighted-average expected life of the option of seven years.

For purposes of adjusted pro forma disclosures, the estimated fair value of the options is amortized to expense over the option’s vesting period. The effect of applying SFAS No. 123 for purposes of providing pro forma disclosures is not likely to be representative of the effects on our operating results for future years because changes in the subjective input assumptions can materially affect future value estimates. Our pro forma information is as follows:

                 
    Three Months ended March 31,
   
    2003   2002
   
 
Net loss, as reported less stock-based compensation expense
  $ (1,082,973 )   $ (729,114 )
Adjusted pro forma basic net loss per share
  $ (0.28 )   $ (0.19 )
Adjusted pro forma diluted net loss per share
  $ (0.28 )   $ (0.19 )

Note E—Sales Commitments

Beginning in 1999 through December 31, 2001, we selectively licensed software to a subset of our customers for non-cancelable three-year terms. Where we provided extended payment terms to customers (allowing them to make payments on a quarterly or annual basis), we recognized license revenue when invoices came due, as SOP 97-2 precluded us from recognizing the portion of these licenses that was not currently due from the customer. In 2002 and in the three months ended March 31, 2003, we have not licensed any software in this manner.

We also sign customers to non-cancelable three-year maintenance agreements, which we recognize ratably over the service period. Amounts to be invoiced are not initially reflected on our Balance Sheet and are identified below. As we invoice against these agreements, the invoiced amounts are recorded first to Deferred Revenue and are then recognized as revenue ratably over the service period.

The following table summarizes these multi-year license and maintenance agreement activities showing ending balances not reflected on our Balance Sheet at March 31, 2003:

                         
    Unrecognized Revenue Backlog
   
            Maintenance        
    Licenses   Agreements   Totals
   
 
 
Balances at December 31, 2000
  $ 488,064     $ 3,422,669     $ 3,910,733  
2001 additions
    23,334       2,830,831       2,854,165  
Invoiced and included in Deferred Revenue
    (484,257 )     (3,193,020 )     (3,677,277 )
 
   
     
     
 
Balances at December 31, 2001
    27,141       3,060,480       3,087,621  
2002 additions
          2,508,365       2,508,365  
Invoiced and included in Deferred Revenue
    (27,141 )     (3,011,460 )     (3,038,601 )
 
   
     
     
 
Balances at December 31, 2002
          2,557,385       2,557,385  
First quarter additions
                 
Invoiced and included in Deferred Revenue
          (720,618 )     (720,618 )
 
   
     
     
 
Balances at March 31, 2003
  $     $ 1,836,767     $ 1,836,767  
 
   
     
     
 

Revenue from the current unrecognized revenue backlog will be recognized by the end of the 2nd quarter of 2006.

8


Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS.

Forward-looking Statements

We make forward-looking statements in this quarterly report on Form 10-Q that are subject to risks and uncertainties. These forward-looking statements include information about possible or assumed future results of our financial condition, operations, plans, objectives and performance. When we use the words “believe,” “expect,” “anticipate,” “estimate” or similar expressions, we are making forward-looking statements. Many possible events or factors could affect our future financial results and performance. This could cause our results or performance to differ materially from those expressed in our forward-looking statements. You should consider these risks when you review this document, along with the following possible events or factors:

    national, international, regional and local economic, competitive, geopolitical and regulatory conditions and developments;
 
    the market for document automation software;
 
    market acceptance of our existing products and introduction of new products and enhancements to existing products;
 
    continued profitability of our professional services;
 
    maintaining our relationships with Xerox; and
 
    other uncertainties, all of which are difficult to predict and many of which are beyond our control.

Our actual results could differ materially from those discussed herein, including those set forth in this discussion, under “Certain Factors Affecting Document Sciences Corporation” and other risks detailed from time to time in our SEC reports. In addition, the discussion of our results of operations should be read in conjunction with the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2002 Annual Report on Form 10-K for the fiscal year ended December 31, 2002 and in reports we file with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date of that statement. We assume no obligation to update these forward-looking statements.

Overview

We develop, market and support a family of document automation software products and services used in high volume electronic publishing applications. We were incorporated in Delaware in October 1991 as a wholly owned subsidiary of Xerox. Following our initial public offering of stock in September 1996, Xerox ownership was reduced to approximately 62%. As a result of our tender offer and our exercise of an option to purchase additional shares of Document Sciences owned by Xerox in April 2001, Xerox’s ownership interest has been reduced to approximately 19%.

9


Table of Contents

Critical Accounting Policies

Our discussion and analysis of the financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and judgments, including those related to revenue recognition, computer software costs, allowance for doubtful accounts and valuation allowance for net deferred tax assets. We base our estimates on historical and anticipated results and trends and on assumptions that we believe are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results may differ from our estimates. We believe that the following critical accounting policies and assumptions may involve a higher degree of judgment and complexity than others.

Revenue Recognition. We recognize revenue in accordance with SOP 97-2, Software Revenue Recognition, and SAB No. 101, Revenue Recognition in Financial Statements. Initial license fees are recognized when a contract exists, the fee is fixed and determinable, software delivery has occurred and collection of the receivable is deemed probable. We use the residual method to recognize revenue for all of our license models. Our contracts specifically state the amount of initial and annual license fees due for each type of software licensed. If an undelivered element of the arrangement exists under the license arrangement, revenue is deferred based on vendor-specific objective evidence of the fair value of the undelivered element. If vendor-specific objective evidence of fair value does not exist for all undelivered elements, all revenue is deferred until sufficient evidence exists or all elements have been delivered. We recognize revenue on transactions with payment terms greater than 30 days but less than twelve months from the contract date, if we have a history of successfully collecting from the specific customer without providing concessions. Amounts billed or payments received in advance of revenue recognition are recorded as deferred revenue.

We work in conjunction with our established value added resellers (VARs), with whom we have formal contracts defining the rights and obligations of the parties, to license software to end-users. We license software to our VARs, less a discount, from a fixed price list. We require a binding purchase order as evidence of an unconditional order by an end user from our VARs, with no rights of return or acceptance. License revenue from our VARs is recognized when software is licensed to an end user.

Annual renewal license and support fees (ALF) are recognized ratably over the contract period. Included in our ALF are unspecified maintenance releases. Our contracts do not provide for specific upgrades. Our standard contracts do not provide for rights of return or conditions of acceptance; however, in the rare case that acceptance criteria are provided, revenue is deferred and not recognized until all conditions are satisfied and written customer acceptance is obtained. We believe this approach to revenue recognition, when acceptance criteria exist, would not result in materially different amounts being reported under different conditions or using different assumptions.

Revenues generated from consulting services are recognized as the related services are performed and collectibility is deemed probable. However, when such consulting services are deemed to be essential to the functionality of the delivered software product, revenue from the entire arrangement is recognized on a percentage of completion method or not until the contract is completed in accordance with SOP 81-1, Accounting for Performance of Construction-Type and Certain Production-Type Contracts, and

10


Table of Contents

Accounting Research Bulletin (ARB) No. 45, Long-Term Construction-Type Contracts. We measure progress under the percentage of completion method, depending on how the contract language is written, either by using the percentage of total project hours completed or by the completion of phases in the consulting project. Because (i) the phases of our consulting projects are generally not of great duration (2-6 weeks on average) and (ii) we have a variety of projects progressing at the same time, we believe that there are very limited circumstances where materially different amounts would be reported under different conditions or using different assumptions.

We consider our anticipated revenue levels when making decisions about our operating expenses. Since a high percentage of those expenses are relatively fixed, a delay in the recognition of revenue from license transactions could cause significant variations in operating results from quarter to quarter, and we may sustain losses as a result. Since revenue may not be recognized in the same quarter as when shipment occurs and if such fixed expenses are incurred before we recognize revenues for these shipments, our operating results would be materially adversely affected.

Software Development Costs. In accordance with SFAS No. 86, Accounting for the Costs of Computer Software to be Sold, Leased or Otherwise Marketed, costs incurred in the research and development of new software products and significant enhancements to existing software products are expensed as incurred until technological feasibility of the product has been established. After technological feasibility has been established, direct production costs, including programming and testing, are capitalized until general release of the product.

Capitalized costs of software to be sold, licensed or otherwise marketed are amortized using the greater of the amount computed using the ratio of current period product revenues to estimated total product revenues or the straight-line method over the remaining estimated economic lives of the products. It is possible that estimated total product revenues, the estimated economic life of the product, or both, will be reduced in the future. As a result, the carrying amount of capitalized software costs may be reduced in the future, which could cause our operating results in future periods to be adversely affected.

Allowance for Doubtful Accounts. We maintain an allowance for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required, which would result in an additional general and administrative expense in the period such determination is made. At the end of each reporting period, we perform a rigorous review of outstanding balances by customer and invoice. We utilize statistical and account specific analysis to determine the adequacy of our reserve, as well as comparing balances to historical losses. If our assumptions or analysis are incorrect, our operating results for future periods may be adversely affected.

Deferred Income Taxes. Deferred income taxes reflect the net effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. At December 31, 2002, we had net deferred tax assets of $1.9 million. Due to the uncertainty of realizing a portion of these net deferred tax assets, we have maintained a valuation allowance of $1.6 million for net deferred tax assets. Such uncertainty primarily relates to the potential for future taxable income as well as loss carryforwards and tax credits expiring in 2018 and 2012, respectively. In addition, pursuant to Sections 382 and 383 of the Internal Revenue Code, annual use of our net operating loss carryforwards may be limited in the event of a cumulative change in ownership of more than 50% within a three-year period. No valuation allowance has been recorded to offset the remaining $305,000 of net deferred tax assets as we have determined that it is more likely than not that these assets will be realized during the year ending December 31, 2003. We will continue to assess the

11


Table of Contents

likelihood of realization of such assets; however, if future events occur which do not make the realization of such assets more likely than not, we will record a valuation allowance against all or a portion of these net deferred tax assets. An example of a future event that may occur which would make the realization of such assets not likely is a lack of taxable income resulting from poor operating results. Based on our operating results for the quarter ended March 31, 2003, we recorded a full valuation allowance for net operating losses generated during the quarter.

Results of Operations

Three Months Ended March 31, 2003 Compared to Three Months Ended March 31, 2002

The following table sets forth the percentage of total revenues, cost of revenues, operating expenses and other items in our consolidated statements of income for the periods indicated:

                       
          Three Months Ended
          March 31,
         
          2003   2002
         
 
Revenues:
               
 
Initial license fees
    23 %     28 %
 
Annual renewal license and support fees
    56       47  
 
Services and other
    21       25  
 
 
   
     
 
   
Total revenues
    100       100  
Cost of revenues:
               
 
Initial license fees
    6       7  
 
Annual renewal license and support fees
    8       8  
 
Services and other
    15       14  
 
 
   
     
 
   
Total cost of revenues
    29       29  
 
 
   
     
 
Gross profit
    71       71  
Operating expenses:
               
 
Research and development
    30       33  
 
Selling and marketing
    48       35  
 
General and administrative
    15       15  
 
 
   
     
 
     
Total operating expenses
    93       83  
 
 
   
     
 
Loss from operations
    (22 )     (12 )
 
Interest and other income, net
    1        
 
 
   
     
 
Loss before income taxes
    (21 )     (12 )
 
Provision for income taxes
           
 
 
   
     
 
Net loss
    (21 )%     (12 )%
 
 
   
     
 

Revenues

Total revenues decreased 4% to $4.6 million for the three months ended March 31, 2003 from $4.8 million for the three months ended March 31, 2002, primarily due to a decline in initial license fees. Services and other revenue also declined, while annual license fees grew.

Sales Channels. We sell our products largely through a direct sales force domestically and through VARs internationally, with the majority of international revenue being derived from Xerox affiliates as discussed below. Revenues from export sales and sales through our foreign subsidiary increased 33% to

12


Table of Contents

$1.3 million for the three months ended March 31, 2003 from $978,400 for the three months ended March 31, 2002. This increase is the result of higher revenues in Canada, Australia and Europe. Revenues from export sales were 28% and 20% of total revenues for the three months ended March 31, 2003 and 2002, respectively.

We maintain VAR agreements with various Xerox foreign affiliates to remarket our products internationally. Our revenues from such agreements related to the licensing, maintenance and support of our products increased 22% to $852,900 for the three months ended March 31, 2003 from $699,900 for the three months ended March 31, 2002. Increased revenues were reported for our Canadian and Australian Xerox affiliates.

Initial license fees. Initial license fees decreased 29% to $1.0 million for the three months ended March 31, 2003 from $1.4 million for the three months ended March 31, 2002. This decrease is due to lower sales in the United States attributable to elongated sales cycles caused by the weak economy, uncertainty generated by geopolitical factors, tighter budgets and our new product introduction.

Annual renewal license and support fees. Annual renewal license and support fees increased 13% to $2.6 million for the three months ended March 31, 2003 from $2.3 million for the three months ended March 31, 2002. This increase is due to growth in our base of licensed software and in our list prices.

Services and other. Revenues from services and other decreased 20% to $961,000 for the three months ended March 31, 2003 from $1.2 million for the three months ended March 31, 2002. This decrease is largely due to an increase in unbillable time related to personnel training in the use of xPression™.

Cost of Revenues

Cost of initial license fees. Costs of initial license fees were 25% and 26% of initial license fees for the three months ended March 31, 2003 and 2002, respectively. This decrease was due to less amortization of software development costs.

Cost of annual renewal license and support fees. Costs of annual license fees were 14% and 16% of annual license fees for the three months ended March 31, 2003 and 2002, respectively. This decrease was due to increased utility of our technical support staff, as our costs remained flat while our revenue increased.

Cost of services and other. Costs of services and other were 71% and 57% of services and other for the three months ended March 31, 2003 and 2002, respectively. This increase was due to lower services and other revenue, while our absolute costs remained flat.

Operating Expenses

Research and development. Research and development expenses decreased 13% to $1.4 million for the three months ended March 31, 2003 from $1.6 million for the three months ended March 31, 2002. We capitalized $218,300 and $163,100 of software development costs for the three months ended March 31, 2003 and 2002, respectively. Notwithstanding capitalized software costs, research and development expenses decreased approximately $167,800 or 9% for the three months ended March 31, 2003. This decrease is due primarily to decreased expenditures for outside consultants and a decrease in allocated facility and communication costs.

13


Table of Contents

Selling and marketing. Selling and marketing expenses increased 29% to $2.2 million for the three months ended March 31, 2003 from $1.7 million for the three months ended March 31, 2002. This increase is due primarily to increased personnel, advertising and tradeshow expenses due to our recent release of xPression.

General and administrative. General and administrative expenses decreased 7% to $689,800 for the three months ended March 31, 2003 from $744,600 for the three months ended March 31, 2002. This decrease is primarily due to lower salary-related costs and a decrease in allocated facility and communication costs.

Provision for income taxes. For the three months ended March 31, 2003, we have recognized $23,410 as income tax expense as a result of foreign taxes. No valuation allowance has been recorded to offset the remaining $305,000 of net deferred tax assets as we have determined that it is more likely than not that these assets will be realized during the year ending December 31, 2003. Based on our operating results for the quarter ended March 31, 2003, we recorded a full valuation allowance for net operating losses generated during the quarter.

Liquidity and Capital Resources

Our cash and cash equivalents and short-term investments totaled $9.7 million at March 31, 2003, representing 51% of total assets. We intend to continue to invest in short-term, interest-bearing, investment grade securities.

Net cash provided by operating activities increased 88% to $1.5 million for the three months ended March 31, 2003 from $798,400 for the three months ended March 31, 2002. This increase is due largely to a favorable change in operating assets and liabilities.

Net cash used in investing activities was $2.0 million for the three months ended March 31, 2003. Net cash provided by investing activities was $188,640 for the three months ended March 31, 2002. Cash used in investing activities for the three months ended March 31, 2003 related primarily to using excess cash to purchase short-term investments.

Net cash provided by financing activities was $27,100 for the three months ended March 31, 2003. Net cash used in financing activities was $2.5 million for the three months ended March 31, 2002. Cash used in financing activities for the three months ended March 31, 2002 related primarily to the payment of notes to Xerox pursuant to our 2001 tender offer.

We believe that our existing cash balances and anticipated cash flows from operations will be sufficient to meet our anticipated cash needs for working capital and capital expenditures for at least the next twelve months.

We have no significant capital spending or purchase commitments other than normal purchase commitments and commitments under facilities leases.

Certain Factors Affecting Document Sciences Corporation

The following is a discussion of certain factors that currently impact or may impact our business, operating results and/or financial condition. Anyone making an investment decision with respect to our common stock or other securities is cautioned to carefully consider these factors. If any of the following risks actually occur, our business, results of future operations and financial condition could be

14


Table of Contents

materially adversely affected. In such case, the trading price of our common stock could decline and you may lose all or part of your investment.

Our quarterly results fluctuate significantly, and we may not be able to grow our business.

Our total revenues and operating results can vary, sometimes substantially, from quarter to quarter, and we expect them to vary significantly in the future. For instance, historically our revenues for the first quarter of the fiscal year have been lower than our revenues for the remaining quarters of the fiscal year. This disparity has adversely impacted, and may continue to adversely impact, our fiscal year end results from operations.

Additionally, our revenues and operating results are difficult to forecast, and our future results will depend upon many factors, including the following:

    the demand for our products;
 
    the level of product competition and price competition;
 
    the length of our sales cycle;
 
    the size and timing of individual license transactions;
 
    the delay or deferral of customer implementations;
 
    the budget cycles of our customers;
 
    our success in expanding our direct sales force and indirect distribution channels;
 
    the timing of our new product introductions and enhancements, as well as those of our competitors;
 
    our mix of products and services;
 
    our level of international sales;
 
    the activities of and acquisitions by our competitors;
 
    our timing of new hires;
 
    changes in foreign currency exchange rates;
 
    our ability to develop and market new products and to control costs; and
 
    general domestic and international economic conditions.

Our initial license fee revenues mainly depend on when orders are received and shipped. However, because of our sales model, our customers’ implementation schedule and the complexity of the implementation process, revenue from some software shipments may not be recognized in the same quarter as the shipment occurs. Our operating expenses are primarily based on anticipated revenue levels. Since a high percentage of those expenses are relatively fixed, a delay in the recognition of revenue from license transactions could cause significant variations in operating results from quarter to quarter, and we may sustain losses as a result. If such expenses precede increased revenues, our operating results would be materially adversely affected.

As a result of these factors, results from operations for any quarter are subject to significant variation, and we believe that period-to-period comparisons of our results of operations are not necessarily meaningful. Accordingly, you should not rely upon them as an indication of our future performance. Furthermore, our operating results in some future quarter may fall below the expectations of public

15


Table of Contents

market analysts and investors. If this occurs, the price of our common stock would likely be materially adversely affected.

We currently derive a significant portion of our revenues with Xerox.

We currently have a variety of contractual and informal relationships with Xerox and affiliates of Xerox, including a cooperative marketing agreement, a transfer and license agreement and various distribution agreements. We rely on these relationships and agreements for a significant portion of our total revenues. Revenues derived from relationships with Xerox and affiliates of Xerox accounted for approximately $982,100 and $755,400 for the three months ended March 31, 2003 and 2002, respectively, representing 21% and 16% of our total revenues respectively.

There can be no assurance that existing and potential customers will continue to do business with us because of these relationships or our historical ties with Xerox and its affiliates. Though we intend to continue our existing relationships with Xerox, our strategy is to lessen our dependence on Xerox. However, there can be no assurance that we will be able to do so and, because of our current level of dependence on Xerox, there can be no assurance that our move to become more independent will not adversely affect our business, results of operations and financial condition. Our failure to maintain these relationships, particularly with Xerox and its affiliates, or to establish new relationships in the future, could have a material adverse effect on our business, operating results and financial condition.

Xerox has strategic alliances and other business relationships with other companies who supply software and services used in high volume electronic publishing applications and who now are or in the future may become our competitors. There can be no assurance that Xerox or one of its affiliated companies will not engage in business that directly competes with us. In addition, Xerox has ongoing internal development activities that could in the future lead to products that compete with us. Xerox could in the future expand these relationships or enter into additional ones, and as a result our business could be materially adversely affected.

Our growth is dependent upon successfully protecting our proprietary rights.

We rely on a combination of copyright and trademark laws, trade secrets, confidentiality procedures and contractual provisions to protect our proprietary rights. Despite these precautions, it may be possible for unauthorized third parties to copy portions of our products or use information we consider proprietary. Policing unauthorized use of our products is difficult and, while we are unable to determine the extent to which piracy of our software products exists, we expect software piracy to be a persistent problem. In addition, the laws of some foreign countries do not protect our proprietary rights to as great an extent as do the laws of the United States. We cannot assure you that our means of protecting our proprietary rights will be adequate or that our competitors will not independently develop similar technology.

We are not aware of any infringement of our products upon the proprietary rights of third parties. However, we cannot assure you that third parties will not claim infringement by us with respect to current or future products. We expect that software product developers will increasingly be subject to infringement claims as the number of products and competitors in our industry segment grows and the functionality of products in different industry segments overlaps. Any such claims, with or without merit, could be time consuming, result in costly litigation, cause product shipment delays or require us to enter into royalty or licensing agreements. Such royalty or licensing agreements, if required, may not be available on terms acceptable to us or at all, which could have a material adverse effect upon our business, operating results and financial condition.

16


Table of Contents

Our growth is dependent upon successfully focusing our distribution channels.

To grow our business, we must streamline our worldwide sales and distribution channels by focusing on key target industry market segments where our current and planned products can enjoy a significant competitive advantage and high market demand. We also must leverage our existing relationships with Xerox, IBM Corporation and their distribution channels and affiliates by launching targeted joint marketing and value added reseller programs and by introducing new product offerings that are optimized for selected target markets and marketing channels. Additionally, we must form additional partnerships with system integrators and consultants in order to broaden our capacity to deliver complete document automation solutions that incorporate significant services content, while also maintaining our core domain expertise. We cannot assure you that we will be able to successfully streamline and focus our worldwide channels, leverage our existing relationships or form new alliances. If we fail to do so, it will have a material adverse effect on our business, operating results and financial condition.

Maintaining our professional services expertise is necessary for our future growth.

We are continuing our focus on the consulting services component of our professional services to assist customers in the planning and implementation of enterprise-wide, mission-critical document automation applications. This strategy is dependent on retaining and hiring professionals to perform these consulting services. Should we be unable to maintain the necessary services workforce, our business and financial condition could be materially adversely affected.

Our growth depends on our ability to compete successfully against current and future competitors.

The market for our document automation products is intensely competitive. We face competition from a broad range of competitors, many of whom have greater financial, technical, and marketing resources than we do. Our principal competition currently comes from systems developed in-house by the internal MIS departments of large organizations and direct competition from numerous software vendors, including Docucorp International, Inc., Metavante Corporation, Group 1 Software, Inc., Exstream Software Inc. and InSystems Technologies, Inc. We believe that the principal competitive factors affecting our market include product performance and functionality, ease of use, scalability, operating across multiple computer and operating system platforms, product and company reputation, client service and support and price. Although we believe we currently compete favorably with respect to such factors, we can not assure you that we will be able to maintain our competitive position against current and future competitors, especially those with greater financial, technical and marketing resources than us, or that we will be successful in the face of increasing competition from new products, new solutions introduced by existing competitors or by new companies entering the market.

Our growth depends on market acceptance of our existing products and our introduction of new products and enhancements to existing products.

Our future business, operating results and financial condition will depend upon market acceptance of our existing products, as well as our ability to respond to emerging industry standards and practices and to develop new products that address the future needs of our target markets. Our Autograph™ family of products has been applied mainly to document automation applications producing paper-based documents. We have started to extend our core technology to the Internet, intranets and commercial on-line services. However, we cannot assure you that we will be successful in developing, introducing and marketing new products or product enhancements, including new products or the extension of existing products for the Internet, intranets and commercial on-line services, on a timely and cost effective basis, if at all. In addition, we cannot assure you that our new products, such as xPression, or enhancements to

17


Table of Contents

existing products will adequately meet the requirements of the marketplace or achieve market acceptance. Moreover, delays in our commercial shipments of new products or enhancements may result in client dissatisfaction and a delay or loss of product revenues.

If for technological or other reasons we are unable to develop and introduce new products or enhancements of existing products in a timely manner in response to changing market conditions or client requirements, then our business, operating results and financial condition will be materially adversely affected. In addition, we cannot assure you that our existing products, new products or new versions of our existing products will achieve market acceptance. In order to provide our customers with integrated product solutions, our future success will also depend in part upon our ability to maintain and enhance relationships with our technology partners.

A longer than expected sales cycle may affect our revenues and operating results.

The licensing of our software products is often an enterprise-wide decision by prospective customers and generally involves a sales cycle of three to twelve months in order to educate our prospective customers regarding the use and benefits of our products. In addition, the implementation of our products by customers involves a significant commitment of their resources over an extended period of time, and is commonly associated with substantial customer business process reengineering efforts. For these and other reasons, our sales and customer implementation cycles are subject to a number of significant delays over which we have little or no control. Any delay in the sale or customer implementation of a limited number of license transactions could have a material adverse effect on our business and results of operations and cause our operating results to vary significantly from quarter to quarter.

Our operating results are substantially dependent on sales of a small number of products in highly concentrated industries.

We derived 49%, 37% and 14% of our initial license revenues for the three months ended March 31, 2003 from our CompuSet, DLS and xPression product lines, respectively. As a result, factors that may adversely impact the pricing of or demand for these products, such as competition from other products, negative publicity or obsolescence of the hardware or software environments in which our products run, could have a material adverse effect on our business, operating results and financial condition. Our financial performance will depend significantly on the successful development, introduction and customer acceptance of new and enhanced versions of our xPression software, as well as continued customer acceptance of CompuSet, DLS and related products.

Licenses to end users in the insurance, finance and print service industries accounted for 100% of domestic initial license revenues for the three months ended March 31, 2003. Our future success will depend on our ability to continue to successfully market our products in these and other industries. Our failure to do so would have a material adverse effect on our business, operating results and financial condition.

We may be exposed to risks associated with international operations.

Our revenues from export sales, including sales through our foreign subsidiary, accounted for 28% and 20% of our total revenues for the three months ended March 31, 2003 and 2002, respectively.

Our wholly owned subsidiary, Document Sciences Europe, markets and supports our products in Europe, for which they receive an agent fee. We license our products in Europe through VARs and to a lesser extent, direct sales. Our VARs are principally Xerox affiliates who re-market our products. Revenues

18


Table of Contents

generated by the activities of Document Sciences Europe were $697,100 and $639,000 for the three months ended 2003 and 2002, respectively.

In Australia, Canada and Latin America, we distribute our products through Xerox affiliates and by direct sale in Canada. Revenues generated in these regions were $574,700 and $339,500 for the three months ended 2003 and 2002, respectively.

In order to successfully expand export sales, we must establish additional foreign operations, hire additional personnel and develop relationships with additional international resellers. If we are unable to do so in a timely manner, our growth in international export sales could be limited, and our business, operating results and financial condition could be materially adversely affected. In addition, we cannot assure you that we will be able to maintain or increase international market demand for our products.

Additional risks inherent in our international business activities include:

    currency fluctuations;
 
    unexpected changes in regulatory requirements;
 
    tariffs and other trade barriers;
 
    our limited experience in localizing products for foreign countries;
 
    lack of acceptance of our localized products in foreign countries;
 
    longer accounts receivable payment cycles;
 
    difficulties in managing our international operations;
 
    potentially adverse tax consequences including restrictions on the repatriation of earnings; and
 
    the burdens of complying with a wide variety of foreign laws.

A portion of our business is conducted in currencies other than the U.S. Dollar, primarily the Euro. Although exchange rate fluctuations have not had a significant impact on us, fluctuations in the value of the currencies in which we conduct our business relative to the U.S. Dollar could cause currency transaction gains and losses in future periods. We do not currently engage in currency hedging transactions, and we cannot assure you that fluctuations in currency exchange rates in the future will not have a material adverse impact on our international revenues and our business, operating results and financial condition.

Our business is dependent on the market for document automation software.

The market for document automation software is intensely competitive, highly fragmented and subject to rapid change. We cannot assure you that the market for document automation software will grow or that, if it does grow, organizations will adopt our products. We have spent, and intend to continue to spend, significant resources educating potential customers about the benefits of our products. However, we cannot assure you that such expenditures will enable our products to achieve further market acceptance, and if the document automation software market fails to develop or develops more slowly than we currently anticipate, our business, operating results and financial condition would be materially adversely affected.

In addition, the commercial market for document automation of electronic documents designed for use with the Internet, intranets and commercial on-line services has only recently begun to develop, and the

19


Table of Contents

success of our products designed for this market will depend in part on their compatibility with such services. It is difficult to predict whether the demand for related products and services would increase or decrease in the future. Since the increased commercial use of the Internet, intranets and commercial on-line services could require substantial modification and customization of certain of our products and services as well as the introduction of new products and services, we cannot assure you that we will be able to effectively or successfully compete in this market.

Our ability to manage our growth will affect our business.

Our ability to compete effectively and to manage future change will require us to continue to improve our financial and management controls, reporting systems and procedures on a timely basis and to expand, train and manage our work force. We cannot assure you that we will be able to do so successfully. Our failure to do so could have a material adverse effect on our business, operating results and financial condition.

Our executive officers and certain key personnel are critical to our business, and these officers and key personnel may not remain with us in the future.

Our future performance depends in significant part upon the continued service of our key technical, sales and senior management personnel. Only our President and Chief Executive Officer and Chief Scientist have signed employment agreements with us. The loss of the services of one or more of our executive officers could have a material adverse effect on our business, operating results and financial condition. Our future success also depends on our continuing ability to attract and retain highly qualified product development, sales and management personnel. Competition for such personnel is intense, and there can be no assurance that we will be able to retain our key employees or that we will be able to attract or retain other highly qualified product development, sales and managerial personnel in the future.

Our failure to adequately limit our exposure to product liability claims may adversely affect us.

Our license agreements with our customers typically contain provisions designed to limit our exposure to potential product liability claims. However, it is possible that the limitation of liability provisions contained in our license agreements may not be effective under the laws of certain jurisdictions. Although we have not experienced any product liability claims to date, sale and support of our products may entail the risk of such claims in the future. A successful product liability claim brought against us or a claim arising as a result of our professional services could have a material adverse effect upon our business, operating results and financial condition.

Our products may suffer from defects or errors.

Software products as complex as those we offer, may contain undetected defects or errors when first introduced or as new versions are released. As a result, we could in the future lose or delay recognition of revenues as a result of software errors or defects. In addition, our products are typically intended for use in applications that may be critical to a customer’s business. As a result, we expect that our customers and potential customers have a greater sensitivity to product defects than the general market for software products. Although our business has not been adversely affected by any such errors to date, we cannot assure you that, despite our testing and testing by current and potential customers, errors will not be found in our existing products or new products or releases. If these errors are discovered after the commencement of commercial shipments, it could result in any of the following:

20


Table of Contents

    loss of revenue or delay in market acceptance;
 
    diversion of our development resources;
 
    damage to our reputation; or
 
    increased service and warranty costs.

If any of these factors occur, it would have a material adverse effect upon our business, operating results and financial condition.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Foreign Currency Exchange Risk

Our earnings and cash flows are subject to fluctuations due to changes in foreign currency exchange rates. To a certain extent, foreign currency exchange rate movements also affect our competitive position, as exchange rate changes may affect business practices and/or pricing strategies on non-U.S. based competitors. The primary foreign currency risk exposure is related to U.S. Dollar to Euro conversions. Considering the anticipated cash flows from firm sales commitments and anticipated sales for the next quarter, a hypothetical 10% weakening of the U.S. Dollar relative to all other currencies would not materially adversely affect expected second quarter 2003 earnings or cash flows. This analysis is dependent on actual export sales during the next quarter occurring within 90% of budgeted forecasts. The effect of the hypothetical change in exchange rates ignores the affect this movement may have on other variables including competitive risk. If it were possible to quantify this competitive impact, the results could well be different than the sensitivity effects described above. In addition, it is unlikely that all currencies would uniformly strengthen or weaken relative to the U.S. Dollar. In reality, some currencies may weaken while others may strengthen. Each month we review our position for expected currency exchange rate movements. Under our current policies, we do not use currency derivatives or other financial instruments to manage or reduce exposure to changes in foreign currency exchange rates.

Interest Rate Risk

We are exposed to changes in interest rates primarily from our short-term available-for-sale investments. Under our current policies, we do not use interest rate derivatives or other financial instruments to manage or reduce exposure to interest rate changes. A hypothetical 100 basis point adverse move in interest rates along the entire interest rate yield curve would not materially affect the fair value of our interest sensitive financial instruments at March 31, 2003. Declines in interest rates over time will, however, reduce our interest income.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Within 90 days before the date of this quarterly report on Form 10-Q, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures. That evaluation was performed under the supervision and with the participation of our management, including our Chief Executive Officer, who also serves as our Chief Financial Officer. Based on that evaluation, our Chief Executive Officer concluded that our disclosure controls and procedures are effective in timely alerting him to material information relating to Document Sciences required to be included in our periodic SEC filings.

21


Table of Contents

Changes in Internal Controls

We have made no significant changes in our internal controls or in other factors that could significantly affect our internal controls since the date of our evaluation.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are not involved in any material legal proceedings.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

No matters were submitted to a vote of security holders during the quarter ended March 31, 2003.

ITEM 5. OTHER INFORMATION

Pre-Approval of Non-Audit Services

Our independent auditors provided no non-audit services during the period covered by this quarterly report on Form 10-Q.

Minimum Advance Notice of Stockholder Proposals

Document Sciences stockholders are advised that we must be notified by no later than December 6, 2003 of any proposal or solicitation that any stockholder intends to present at the next annual meeting of stockholders and which the stockholders has not sought to have included in our proxy statement for the meeting in accordance with Rule 14a-8 under the Securities Exchange Act of 1934. If a proponent fails to notify us before the required deadline, management proxies will be allowed to use their discretionary voting authority if the proposal is raised at the 2003 annual meeting, without any discussion of the matter in the proxy statement.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

(a)   Exhibits.
 
    Set forth below is a list of the exhibits included as part of this Quarterly Report.

             
Exhibit    
Number   Exhibit Description

 
3.1       (1)   Restated Certificate of Incorporation of the Registrant filed May 1, 1992.
3.2       (1)   Form of Amended and Restated Certificate of Incorporation of the Registrant.
3.3       (1)   Amended and Restated Bylaws of the Registrant.
3.4       (1)   Form of Certificate of Amendment of Certificate of Incorporation of the Registrant.
4.1       (1)   Specimen Stock Certificate.
4.2       (6)   Rights Agreement Between the Registrant and U.S. Stock Transfer Corporation, as
            Rights Agent, dated May 11, 2001, which includes as Exhibit A thereto the form of Rights Certificate to be Distributed to Holders of Rights after the Distribution Date (as that term is defined in the Rights Agreement).
10.1       (1, 2)   Form of Indemnity Agreement Between the Registrant and each of its Officers and Directors.
10.2       (1, 2)   1993 Stock Option Plan and Form of Agreement.

22


Table of Contents

             
Exhibit    
Number   Exhibit Description

 
10.3       (4)   1995 Stock Incentive Plan and Form of Agreement, as amended.
10.4       (1, 2)   Stockholder Rights Agreement Dated September 1996 Between the Registrant and Xerox Corporation.
10.5       (1)   Tax Sharing Agreement Dated August 1996 Between the Registrant and Xerox Corporation.
10.6       (1)   Transfer and License Agreement Dated July 1, 1992, as Amended in September 1994, Between the Registrant and Xerox Corporation.
10.7       (1)   Strategic Marketing Alliance Agreement Dated September 1, 1993, Between the Registrant and Xerox Corporation.
10.8       (4)   1997 Employee Stock Purchase Plan, as amended.
10.9       (3)   Xerox Cooperative Marketing Agreement.
10.10       (3)   Xerox Canada Cooperative Marketing and Customer Support Agreement.
10.11       (4)   International Business Machines Marketing Agreement.
10.12       (4)   Lease for Company’s new Principal Facilities, as Amended, and Assignment of Lease.
10.13       (2, 5)   John L. McGannon Employment Agreement.
10.14       (6)   Form of Software License and Software Support Agreement.
10.15       (6)   Form of Professional Services Agreement.
10.16       (6)   Form of Value Added Reseller Agreement.
10.17       (6)   Development Services and Referral Agreement Between Objectiva Software Solutions, Inc. and the Registrant.
99.1           Certification of CEO/CFO Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


(1)   Previously filed as exhibits to Registration Statement on Form S-1 Registration Number 333-06344.
 
(2)   Indicates management compensatory plan, contract or arrangement.
 
(3)   Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 1997.
 
(4)   Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 1998.
 
(5)   Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2000.
 
(6)   Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001.

(b)   Reports on Form 8-K.
 
    We filed the following Current Report on Form 8-K during the first quarter of 2003:

              On February 18, 2003, we filed a Current Report on Form 8-K that included a press release issued on February 14, 2003, announcing transfer of the listing of our common stock from the Nasdaq National Market to the Nasdaq SmallCap Market.

23


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

         
    Document Sciences Corporation
(Registrant)
         
Date: May 12, 2003   /s/ John L. McGannon    
   
   
    John L. McGannon
President, Chief Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Financial Officer)
   

24


Table of Contents

CERTIFICATION

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

     I, John L. McGannon, certify that:

     1.     I have reviewed this quarterly report on Form 10-Q of Document Sciences Corporation;

     2.     Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

     3.     Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

     4.     I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and I have:

            a.     Designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to me by others within those entities, particularly during the period in which this quarterly report is being prepared;

            b.     Evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

            c.     Presented in this quarterly report my conclusions about the effectiveness of the disclosure controls and procedures based on my evaluation as of the Evaluation Date;

     5.     I have disclosed, based on my most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

            a.     All significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

            b.     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

     6.     I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of my most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

     
     
Dated: May 12, 2003   /s/ John L. McGannon
   
    John L. McGannon
President, Chief Executive Officer and Chief Financial Officer

25


Table of Contents

EXHIBIT INDEX

                     
Exhibit            
Number   Exhibit Description   Page

 
 
3.1       (1)   Restated Certificate of Incorporation of the Registrant filed May 1, 1992.
3.2       (1)   Form of Amended and Restated Certificate of Incorporation of the Registrant.
3.3       (1)   Amended and Restated Bylaws of the Registrant.
3.4       (1)   Form of Certificate of Amendment of Certificate of Incorporation of the Registrant.
4.1       (1)   Specimen Stock Certificate.
4.2       (6)   Rights Agreement Between the Registrant and U.S. Stock Transfer Corporation, as Rights Agent, dated May 11, 2001, which includes as Exhibit A thereto the form of Rights Certificate to be Distributed to Holders of Rights after the Distribution Date (as that term is defined in the Rights Agreement).
10.1       (1, 2)   Form of Indemnity Agreement Between the Registrant and each of its Officers and Directors.
10.2       (1, 2)   1993 Stock Option Plan and Form of Agreement.
10.3       (4)   1995 Stock Incentive Plan and Form of Agreement, as amended and restated.
10.4       (1, 2)   Stockholder Rights Agreement Dated September 1996 Between the Registrant and Xerox Corporation.
10.5       (1)   Tax Sharing Agreement Dated August 1996 Between the Registrant and Xerox Corporation.
10.6       (1)   Transfer and License Agreement Dated July 1, 1992, as Amended in September 1994, Between the Registrant and Xerox Corporation.
10.7       (1)   Strategic Marketing Alliance Agreement Dated September 1, 1993, Between the Registrant and Xerox Corporation.
10.8       (4)   1997 Employee Stock Purchase Plan, as amended and restated.
10.9       (3)   Xerox Cooperative Marketing Agreement.
10.10       (3)   Xerox Canada Cooperative Marketing and Customer Support Agreement.
10.11       (4)   International Business Machines Marketing Agreement.
10.12       (4)   Lease for Company’s new Principal Facilities, as Amended, and Assignment of Lease.
10.13       (2, 5)   John L. McGannon Employment Agreement.
10.14       (6)   Form of Software License and Software Support Agreement.
10.15       (6)   Form of Professional Services Agreement.
10.16       (6)   Form of Value Added Reseller Agreement.
10.17       (6)   Development Services and Referral Agreement Between Objectiva Software Solutions, Inc. and the Registrant.
99.1           Certification of CEO/CFO Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


(1)   Previously filed as exhibits to Registration Statement on Form S-1 Registration Number 333-06344.
 
(2)   Indicates management compensatory plan, contract or arrangement.
 
(3)   Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 1997.
 
(4)   Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 1998.
 
(5)   Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2000.
 
(6)   Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001.

26